Effect of 10mg Domperidone on Gastric Emptying of a High-fat Meal and Appetite Sensations in Healthy Adults
NCT01347814 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 13
Last updated 2011-05-04
Summary
The purpose of this study is to determine whether domperidone was sufficient to accelerate gastric emptying of a high-fat solid meal and reduce satiety responses in a healthy adult population.
Conditions
Interventions
- DRUG
-
Domperidone 10mg
10mg domperidone tablet 30 minutes before a test-meal.
- DRUG
-
Homeopathic (Sugar) pill-Placebo
Sponsors & Collaborators
-
Irish Research Council
collaborator OTHER -
University of Limerick
lead OTHER
Principal Investigators
-
Amir Shafat · University of Limerick
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- SINGLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 10 Years
- Max Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2008-02-29
- Primary Completion
- 2010-04-30
- Completion
- 2010-04-30
Countries
- Ireland
Study Locations
More Related Trials
-
A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adult Subjects With Idiopathic Gastroparesis.
NCT06899217 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
The Effect of Oxytocin on Gastric Emptying
NCT01152047 ·Status: COMPLETED ·Phase: NA
-
Domperidone in Treating Patients With Gastrointestinal Disorders
NCT01696734 ·Status: RECRUITING ·Phase: PHASE3
-
Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Men With Diabetic Gastroparesis
NCT02025751 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Metoclopramide Nasal Spray Solution in Diabetic Patients With Gastroparesis
NCT00845858 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Relamorelin Administered to Participants With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
NCT02357420 ·Status: COMPLETED ·Phase: PHASE2
-
Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Women With Diabetic Gastroparesis
NCT02025725 ·Status: COMPLETED ·Phase: PHASE3
-
Bioavailability Study of Anti Nausea Medication With and Without Food (EUR-1025)
NCT00981487 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Itopride on Gastric Motor and Sensory Functions in Healthy Volunteers
NCT00370110 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Effect of Bitter Taste Receptor Agonists on The Gastrointestinal Tract, Hunger and Food Intake
NCT02759926 ·Status: UNKNOWN ·Phase: NA
-
Effect of Relamorelin on Satiation, Gastric Volume, Gastric Accommodation and Distal Gastric Function in Healthy Volunteers
NCT02466711 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Single Doses of GSK962040 in Critically Ill Patients With Enteral Feed Intolerance
NCT01039805 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Promethazine for Treatment of Diabetic Gastroparesis
NCT02130622 ·Status: TERMINATED ·Phase: PHASE2
-
Usefulness of Metoclopramide to Improve Endoscopic Visualization in Upper Gastrointestinal Bleeding
NCT06297954 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Dexmedetomidine on Gastric Emptying and Gastrointestinal Transit
NCT01084473 ·Status: COMPLETED ·Phase: PHASE1
-
To Demonstrate the Relative Bioavailability Study of Ondansetron HCl 24 mg Tablets Under Non-Fasting Conditions
NCT00947128 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Ondansetron on Gastrointestinal Sensorimotor Dysfunctions in Diabetes Mellitus and Dyspepsia
NCT03865290 ·Status: RECRUITING ·Phase: PHASE2
-
Efficacy of Itopride Versus Metoclopramide in Hospitalized Medicine Patients With High Gastric Residual Volume
NCT07031479 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
To Demonstrate the Relative Bioavailability Study of Ondansetron HCl 24 mg Tablets Under Fasting Conditions
NCT00946387 ·Status: COMPLETED ·Phase: PHASE1
-
The Effects of Ondansetron on Brain Function
NCT02460341 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of the Safety, Tolerability and Pharmacokinetics of Repeat Oral Doses of GSK962040 Administered to Healthy Adult Subjects.
NCT00733551 ·Status: COMPLETED ·Phase: PHASE1
-
Dose Response of 28 Days of Dosing of GSK962040 in Type I and II Diabetic Male and Female Subjects With Gastroparesis
NCT01262898 ·Status: COMPLETED ·Phase: PHASE2
-
Nutritional Adequacy Therapeutic Enhancement in the Critically Ill. The NUTRIATE Study
NCT01934192 ·Status: TERMINATED ·Phase: PHASE2
-
Washed Microbiota Transplantation for Diabetic Gastroparesis
NCT06340217 ·Status: RECRUITING ·Phase: NA
-
Bioavailability Study of Anti Nausea Medication With and Without Food
NCT00905190 ·Status: COMPLETED ·Phase: PHASE1